Accendra Health (ACH) Gross Margin (2009 - 2026)
Accendra Health (ACH) reported Gross Margin of 49.76% for Q1 2026, down 2830.0% year-over-year from 1.82% in Q1 2025, and down 2.05% quarter-over-quarter from 50.8% in Q4 2025.
Accendra Health (ACH) Gross Margin (2009 - 2026) Analysis & Trends
Accendra Health (ACH) has 18 years of Gross Margin data on file, last reported at 49.76% in Q1 2026.
- Gross Margin for Q1 2026 came in at 49.76%, down 2830.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 51.35% (down 3000.0% YoY), and the FY2025 annual result was 52.09%, down 3071.0% from the prior year.
- Gross Margin retreated to 49.76% in Q1 2026 per ACH's latest filing, from 50.8% in the prior quarter.
- Over five years, Gross Margin peaked at 83.42% in Q4 2024 and troughed at 11.12% in Q4 2023.
- A 5-year average of 39.65% and a median of 21.3% in 2022 frame the typical range for Gross Margin.
- The sharpest annual moves came in 2024 and 2025: Gross Margin jumped 9454 bps in 2024, then slumped 3261 bps in 2025.
- A 5-year view of Gross Margin shows it stood at 15.96% in 2022, then tumbled by 170 bps to 11.12% in 2023, then surged by 850 bps to 83.42% in 2024, then slumped by 39 bps to 50.8% in 2025, then retreated by 2 bps to 49.76% in 2026.
- Business Quant data shows ACH's Gross Margin at 49.76% in Q1 2026, 50.8% in Q4 2025, and 51.58% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 4.20% |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 4.58% |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 4.10% |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 31.77% |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 49.76% |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | 45.73% |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 5.85% |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 7.70% |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49.76% |
| Dec 31, 2025 | 50.80% |
| Sep 30, 2025 | 51.58% |
| Jun 30, 2025 | 53.14% |
| Mar 31, 2025 | 78.06% |
| Dec 31, 2024 | 83.42% |
| Sep 30, 2024 | 81.49% |
| Jun 30, 2024 | 82.40% |
| Mar 31, 2024 | 20.50% |
| Dec 31, 2023 | -11.12% |
| Sep 30, 2023 | 20.78% |
| Jun 30, 2023 | 20.26% |
| Mar 31, 2023 | 19.71% |
| Dec 31, 2022 | 15.96% |
| Sep 30, 2022 | 20.55% |
| Jun 30, 2022 | 21.30% |
| Mar 31, 2022 | 15.52% |
| Dec 31, 2021 | 13.84% |
| Sep 30, 2021 | 13.14% |
| Jun 30, 2021 | 16.07% |